Part of the renowned Braunwald family of references, Diabeto-Cardiology, 2nd Edition, provides today’s clinicians with clear, authoritative guidance on the complex challenges of providing care to patients with cardiovascular and diabetes co-morbidities. Drs. Darren K. McGuire and Nikolaus Marx, along with a leading team of experts in cardiology and diabetes, address boththe foundational aspects and clinical implications for this growing number of patients, including recent breakthrough therapies and new medications that have contributed to newer and more effective treatments and improved patient outcomes. From cover to cover, this second edition offers reliable and current point-of-care coverage of the interwoven care needs of patients with these complex co-morbidities, making it an ideal resource for practitioners at all levels of experience.
Section 1 Diabetes Mellitus 1. Definition and Epidemiology of Type 2 Diabetes Mellitus 2. Insulin Resistance: Pathophysiology, Molecular Mechanisms, Genetic Insights 3. Lifestyle Interventions for the Prevention of Type 2 Diabetes Mellitus 4. Pharmacological and Surgical Interventions That Prevent or Remit Type 2 Diabetes? 5. Type 1 Diabetes: Pathophysiology and Treatment Considerations for Cardiovascular Risk and Disease
Section 2 Cardiovascular Complications of Type 2 Diabetes 6. Atherosclerosis in Patients with Type 2 Diabetes: Epidemiology 7. Pathology and Vascular Biology of Atherosclerosis in Patients with Type 2 Diabetes: Inflammation, Dyslipidemia, Hypercoagulability, Endothelial Dysfunction, and Inflammation 8. Risk Stratification Among Patients with Type 2 Diabetes with or at Risk for Atherosclerotic Cardiovascular Disease 9. Epidemiology and Pathophysiology of Heart Failure with Preserved and with Reduced Ejection Fraction in Patients with Type 2 Diabetes
Section 3 Effects of Antihyperglycemic Therapies for Type 2 Diabetes on Cardiovascular and Kidney Outcomes 10. Effect of Acute and Chronic Glucose Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 11. Regulatory Approach to Medications for Type 2 Diabetes: Past, Present and Future 12. Cardiovascular and Kidney Effects of Sodium Glucose Co-transporter Inhibitors 13. Cardiovascular and Kidney Effects of Glucagon-like Peptide 1 Receptor Agonists 14. Antihyperglycemic Medications with Proven Cardiovascular Safety 15. Prevention of Heart Failure in Patients with Type 2 Diabetes 16. Treatment of Patients with Reduced and with Preserved Ejection Fraction Heart Failure in Patients with Type 2 Diabetes
Section 4 Management of Coronary Heart Disease Risk, Chronic and Acute Coronary Syndromes in Patients with Type 2 Diabetes 17. Effect of Lifestyle Interventions on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 18. Effect of Blood Pressure Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 19. Effect of Lipid Management on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 20. Effect of Antiplatelet and Anticoagulant Therapies on Coronary Heart Disease Risk in Patients with Type 2 Diabetes 21. Therapeutic Implications of Type 2 Diabetes for Patients Undergoing Percutaneous or Surgical Coronary Revascularization 22. Epidemiology of Acute Coronary Syndromes in Patients with Type 2 Diabetes 23. Antiplatelet and Anticoagulant Therapy in Patients with Type 2 Diabetes with Acute Coronary Syndromes and/or Percutaneous Coronary Intervention
Section 5 Other Cardiovascular Considerations Associated with Type 2 Diabetes 24. Peripheral Artery Disease in Patients with Type 2 Diabetes 25. Cerebrovascular Disease in Patients with Type 2 Diabetes 26. Atrial Fibrillation in Patients with Type 2 Diabetes 27. Chronic Kidney Disease: Implications for Cardiovascular Risk and Management in Patients with Type 2 Diabetes 28. Disparities in Type 2 Diabetes Risk, Cardiovascular Consequences, and Care: Women, Race/Ethnic Minorities, and the Elderly 29. The Quality Chasm - Type 2 Diabetes
Comments (0)
Your review appreciation cannot be sent
Report comment
Are you sure that you want to report this comment?
Report sent
Your report has been submitted and will be considered by a moderator.